REFERENCES
- Akbuga J., Bergisadi N. Effect of drug properties on physical and release characteristics of eudragit microspheres prepared by spherical crystallization technique. Drug Dev. Ind. Pharm. 1997; 23: 407–411, [CSA]
- Aspden T. J., Illum L., Skaugrud Ó. Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur. J. Pharm. Sci. 1996; 4: 23–31, [CROSSREF], [CSA]
- Banakar U. V. Pharmaceautical Dissolution Testing, 1st, Ed. Marcel Dekker, New York 1992; 191–194
- Barichello J. M., Morishita M., Takayama K., Nagai T. Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats. Int. J. Pharm. 1999; 184: 189–198, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bechgaard E., Gizurarson S., Hjortkær R. K., Sørensen A. R. Intranasal administration of insulin to rabbits using glycofural as an absorption promoter. Int. J. Pharm. 1996; 128: 287–289, [CROSSREF], [CSA]
- Berger J., Reist M., Mayer J. M., Felt O., Peppas N. A., Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm 2004; 57(1)19–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chien Y. W., Su K. S. E., Chang S. F. Nasal Systemic Drug Delivery. Marcel Dekker, New York 1989; 89–197
- Chueh H. R., Zia H., Rhodes C. T. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug. Dev. Ind. Pharm. 1995; 21(15)1725–1747, [CSA]
- Deurloo M. J. M., Hermens W. A. J.J., Romeijn S. G., Verhoef J., Merkus F. W. H. M. Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate in rabbits and rats. Pharm. Res. 1989; 6: 853–856, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dondeti P., Zia H., Needham T. E. Bioadhesive and formulation parameters affecting nasal absorption. Int. J. Pharm. 1996; 127: 115–133, [CROSSREF], [CSA]
- Dondeti P., Zia H., Needham T. E., Luzzi L. A. Development of a new non-surgical perfusion technique for evaluation of nasal drug delivery. Pharmazie 1994; 49(7)505–509, [PUBMED], [INFOTRIEVE], [CSA]
- Dong Y. M., Qiu W. B., Ruan Y. H., Wu Y. S., Wang M. A., Xu C. Y. Influence of molecular weight on critical concentration of chitosan/formic acid liquid crystalline solution. Polym. J. 2001; 33: 387–389, [CROSSREF], [CSA]
- Ennis R. D., Borden L., Lee W. A. The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study. Pharm. Res. 1990; 7: 468–475, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gordon G. S., Moses A. C., Silver R. D., Flier J. S., Carey M. C. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proc. Natl. Acad. Sci. USA 1985; 82: 7419–7423, [PUBMED], [INFOTRIEVE], [CSA]
- Guyton A. C. Textbook of Medical Physiology, 8th ed. W.B. Saunders Company, Philadelphia 1991; 9–23
- Hermens W. A. J.J., Merkus F. W. H.M. The influence of drugs on nasal ciliary movement. Pharm. Res. 1987; 4: 445–449, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hinchcliffe M., Illum L. Intranasal insulin delivery and therapy. Adv. Drug Del. Rev. 1999; 35(2)199–234, [CROSSREF], [CSA]
- Hirai S., Ikenaga T., Matsuzawa T. Nasal absorption of insulin in dogs. Diabetes 1978; 27: 296–299, [CSA]
- Hirai S., Yashiki T., Mima H. Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 1981; 9: 165–172, [CROSSREF], [CSA]
- Hussain A. A. Intranasal drug delivery. Adv. Drug Del. Rev. 1998; 29(1)39–49, [CROSSREF], [CSA]
- Illum L., Farraj N. F., Davis S. S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 1994; 11: 1186–1189, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Illum L., Farraj N. F., Critchley H., Johansen B. R., Davis S. S. Enhanced nasal absorption of insulin in rats using lysophosphatidylcholine. Int. J. Pharm. 1989; 57: 49–54, [CROSSREF], [CSA]
- Kiang S. W., Kuan J. W., Kuan S. S., Guilbaulut G. G. Measurement of glucose in plasma, with use of immobilized glucose oxidase and peroxidase. Clin. Chem. 1976; 22: 1378–1382, [PUBMED], [INFOTRIEVE], [CSA]
- Lehr C. M., Bouwstra J. A., Schacht E. H., Junginger H. E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharmacol. 1992; 78: 43–48, [CROSSREF], [CSA]
- Longenecker J. P., Moses A. C., Silver R. D., Carey M. C., Dubovi E. J. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J. Pharm. Sci. 1987; 76: 351–355, [PUBMED], [INFOTRIEVE], [CSA]
- Macheras P., Reppas C., Dressman B. Biopharmaceutics of Orally Administered Drugs. Ellis Harwood, London 1995; 49–77
- Merkus F. W. H.M., Verhoef J. C., Romeijn S. G., Schipper N. G. M. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm. Res. 1991; 8(5)588–591, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mishima M., Wakita Y., Nakano M. Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats. J. Pharmacobio–Dyn. 1987; 10: 624–631, [CSA]
- Morimoto K., Kamiya E., Takeeda T., Nakamoto Y., Morisaka K. Enhancement of rectal absorption of insulin in polyacrylic acid aqueous gel bases containing long chain fatty acid in rats. Int. J. Pharm. 1983; 14: 149–157, [CROSSREF], [CSA]
- Morimoto K., Akatsuchi H., Aikawa R., Morishita M, Morisaka K. Enhanced rectal absorption of [Asu1,7]–eel calcitonin in rats using polyacrylic acid aqueous gel base. J. Pharm. Sci. 1984; 73: 1366–1368, [PUBMED], [INFOTRIEVE], [CSA]
- Morimoto K., Morisaka K., Kamada A. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J. Pharm. Pharmacol. 1985; 37: 134–136, [PUBMED], [INFOTRIEVE], [CSA]
- Muzzarelli Chitosan R., Muzzarelli R. Natural Chelating Polymers. Pergamon Press, Oxford 1973; 144–176
- Najafabadi A., Moslemi P., Tajerzadeh H. Intranasal bioavailability of Insulin from carbopol – based gel spray in rabbits. Drug Deli. 2004; 11(5)295–300, [CROSSREF], [CSA]
- Nishioka Y., Kyotani S., Okamura M., Miyazaki M., Okazaki K., Ohnishi S., Yamamoto Y., Ito K. Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. Chem. Pharmacol. Bull. 1990; 38(10)2871–2873, [CSA]
- Pereswetoff-Morath L., Bjurstrom S., Khan R., Dahlin M, Edman P. Toxicological aspects of the use of dextran microspheres and thermogelling ethyl(hydroxyethyl) cellulose (EHEC) as nasal drug delivery systems. Int. J. Pharm. 1996; 128(1-2)9–21, [CROSSREF], [CSA]
- Pereswetoff-Morath L., Edman P. Influence of osmolarity on nasal absorption of insulin from the thermogelling polymer ethyl(hydroxyethyl) cellulose. Int. J. Pharm. 1995; 125(2)205–213, [CROSSREF], [CSA]
- Sawayanagi Y., Nambu N., Nagai T. Dissolution properties and bioavailability of phenytoin from ground mixtures with chitin or chitosan. Chem. Pharmacol. Bull. 1983; 31: 2064–2068, [CSA]
- Shao Z., Krishnamoorthy R., Mitra A. K. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations. Pharm. Res. 1992; 9(9)1157–1163, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Soane R. J., Frier M., Perkins A. C., Jones N. S., Davis S. S., Illum L. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int. J. Pharm. 1999; 178(1)55–65, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Thanoo B. C., Sunny M. C., Jayakrishnan A. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for controlled release of pharmaceuticals. J. Pharm. Pharmacol. 1992; 44: 283–286, [PUBMED], [INFOTRIEVE], [CSA]
- Ugweke M. I., Verbeke N., Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J. Pharm. Pharmacol. 2001; 53(1)3–22, [CROSSREF], [CSA]
- Varshosaz J., Dehghan Z. Development and physical characterization of buccoadhesive nifedipine tablets. Eur. J. Pharm. Biopharm. 2002; 54: 135–141, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zia H., Dondeti P., Needham T. E. Nasal drug delivery. Clin. Res. Regul. Aff. 1993; 10: 99–135, [CSA]